Thrombosis research

Thromb Res · ISSN (e) 1879-2472 · 12 papers in corpus
other 2022
doi:10.1016/j.thromres.2022.07.014 ·PMID:35932497
review 2019
doi:10.1016/s0049-3848(19)30368-8 ·PMID:31477229

Inherited platelet disorders (IPD) are a heterogeneous group of hemorrhagic diseases affecting both men and women, but usually associated with more evident bleeding symptoms in women due to the exposure to sexspecific hemostatic challenges,…

review 2015
doi:10.1016/s0049-3848(15)50439-8 ·PMID:25903532

miRNAs function as important regulators of a wide range of cellular processes, such as angiogenesis and fibrinolysis, by postranscriptional modulation of gene expression. We present a review on the role of miRNAs and angiogenesis in endomet…

observational 2015
doi:10.1016/j.thromres.2015.11.038 ·PMID:26672897

OBJECTIVE: The aim of this study is to estimate the risk of thromboembolism related to body mass index (BMI) and aging among users of hormonal contraceptives in Japan. METHODS: A case-control study of the risk of obesity and a descriptive …

rct 2014
doi:10.1016/j.thromres.2014.09.014 ·PMID:25283586

INTRODUCTION: The hemostatic and inflammatory systems may activate each other. Endometriosis is a chronic inflammatory disease affecting 10% of women. The objective of this study was to compare the hemostatic effects of two treatments widel…

observational 2010
doi:10.1016/j.thromres.2010.08.010 ·PMID:20833412

INTRODUCTION: Because the risk of venous thromboembolism (VTE) associated with progestin is uncertain, we tested oral contraceptives, estrogen and progestin as independent VTE risk factors. MATERIALS AND METHODS: Using longitudinal, popula…

review 2009
doi:10.1016/j.thromres.2009.06.013 ·PMID:19619892

Tissue factor (TF), is a transmembrane protein whose role was first identified as that of the initiator of hemostasis via a series of complicated protein cascades. It is now known however, that TF participates in angiogenesis as well as sev…

review 2009
doi:10.1016/S0049-3848(09)70151-3 ·PMID:19944259

Based on its pattern of inheritance, von Willebrand disease (VWD) is expected to affect an equal number of men and women. Clinically, however, more women are diagnosed with VWD than men because the bleeding symptoms associated with VWD are …

observational 2008
doi:10.1016/j.thromres.2008.02.010 ·PMID:18423526

INTRODUCTION: Endometriosis is a benign gynecologic disease with a high prevalence. It is a multifactorial and polygenic entity in which the fibrinolytic system may be implicated. The objective of this study was to evaluate the plasminogen …

review 2007
doi:10.1016/j.thromres.2007.03.012 ·PMID:17482662

Menorrhagia is the most common symptom experienced by women with von Willebrand's disease (VWD), but several other gynaecological disorders also occur more frequently in these women; primarily ovarian cysts and endometriosis. Women with VWD…

case-report 1997
doi:10.1016/s0049-3848(97)00163-1 ·PMID:9306621

Danazol, a synthetic attenuated anabolic steroid, has been administered for 36 months to a 32 year old male with hereditary Protein S (PS) deficiency who had become non-compliant for warfarin therapy. The patient has an eleven year history …

case-report 1991
doi:10.1016/s0049-3848(05)80001-5 ·PMID:1808758

Two patients (one male and one female) with end stage renal disease on chronic hemodialysis were treated with recombinant human erythropoietin (r-HuEPO). Both patients developed significant clotting in the vascular access and extracorporeal…